IoMT Development Services

IoMT is a network of connected medical devices, sensors, and software applications that collect, transmit, and exchange health data over the internet without requiring direct human-to-device interaction. It spans everything from wearable fitness and vital-sign trackers to hospital-grade infusion pumps and diagnostic imaging equipment. All these devices feed data into centralized platforms that clinicians and care teams can act on in real time.

Common IoMT devices include wearable heart rate and glucose monitors, smart inhalers, and connected infusion pumps. The list also comprises remote patient monitoring kits for blood pressure and weight, smart pill dispensers, implantable cardiac devices, and hospital equipment like ventilators and imaging systems that report status and diagnostics over a network. On top of that, the category features ingestible sensors and biosensor patches used for continuous, non-invasive monitoring.

Timelines range from around 3-4 months for an MVP or proof of concept to 12-18+ months for a full production system with hardware integration, regulatory documentation, and enterprise deployment.

The most common variables that extend timelines are hardware certification dependencies, the need for clinical validation, and integration with existing EHR or hospital systems. Before committing to a full delivery roadmap, we recommend starting with a clearly bounded first phase, which is about defining architecture, validating core connectivity, and aligning on regulatory classification.

IoMT devices are subject to overlapping requirements. HIPAA governs how patient data is protected in transit and at rest. The FDA’s cybersecurity guidance under Section 524B requires manufacturers to submit a Software Bill of Materials (SBOM) and a Security Risk Management Report with premarket submissions, and to maintain a vulnerability disclosure and patching process throughout the device’s lifecycle. This means building in encryption, authentication, access controls, and monitoring from the design phase.

Yes. We develop software components that qualify as SaMD, including AI/ML-enabled functions, following FDA’s quality system requirements and its guidance on predetermined change control plans for AI models that evolve after deployment. This includes documentation, verification, and validation practices aligned with IEC 62304 and ISO 14971.

Definitely. We build IoMT integrations using HL7 and FHIR standards, the common protocols for exchanging clinical data with EHR/EMR platforms like Epic, Cerner, and Allscripts. This lets device data, such as continuous vital signs or remote monitoring readings, flow directly into a patient’s existing record so that clinicians don’t have to check separate systems manually.